Department of Biomedical Engineering, University of California, Davis, Davis, CA 95616.
Department of Cardiovascular and Internal Medicine, University of California, Davis Medical Center, Sacramento, CA 95817; and.
J Immunol. 2020 Nov 15;205(10):2806-2820. doi: 10.4049/jimmunol.2000485. Epub 2020 Oct 14.
Intermediate monocytes (iMo; CD14CD16) increase in number in the circulation of patients with unstable coronary artery disease (CAD), and their recruitment to inflamed arteries is implicated in events leading to mortality following MI. Monocyte recruitment to inflamed coronary arteries is initiated by high affinity β2-integrin (CD11c/CD18) that activates β1-integrin (VLA-4) to bind endothelial VCAM-1. How integrin binding under shear stress mechanosignals a functional shift in iMo toward an inflammatory phenotype associated with CAD progression is unknown. Whole blood samples from patients treated for symptomatic CAD including non-ST elevation MI, along with healthy age-matched subjects, were collected to assess chemokine and integrin receptor levels on monocytes. Recruitment on inflamed human aortic endothelium or rVCAM-1 under fluid shear stress was assessed using a microfluidic-based artery on a chip (A-Chip). Membrane upregulation of high affinity CD11c correlated with concomitant activation of VLA-4 within focal adhesive contacts was required for arrest and diapedesis across inflamed arterial endothelium to a greater extent in non-ST elevation MI compared with stable CAD patients. The subsequent conversion of CD11c from a high to low affinity state under fluid shear activated phospho-Syk- and ADAM17-mediated proteolytic cleavage of CD16. This marked the conversion of iMo to an inflammatory phenotype associated with nuclear translocation of NF-κB and production of IL-1β We conclude that CD11c functions as a mechanoregulator that activates an inflammatory state preferentially in a majority of iMo from cardiac patients but not healthy patients.
中间型单核细胞 (iMo; CD14CD16) 在不稳定型冠状动脉疾病 (CAD) 患者的循环中数量增加,其向炎症动脉的募集被认为与 MI 后导致死亡的事件有关。单核细胞向炎症性冠状动脉的募集是由高亲和力 β2-整合素 (CD11c/CD18) 启动的,它激活 β1-整合素 (VLA-4) 以结合内皮细胞 VCAM-1。在剪切力下整合素结合如何机械信号传递导致 iMo 向与 CAD 进展相关的炎症表型的功能转变尚不清楚。从接受治疗的有症状 CAD 患者(包括非 ST 段抬高型 MI)以及健康年龄匹配的受试者中采集全血样本,以评估单核细胞上趋化因子和整合素受体的水平。在流体剪切力下,通过基于微流控的动脉芯片 (A-Chip) 评估在炎症人主动脉内皮或 rVCAM-1 上的募集。高亲和力 CD11c 的膜上调与粘着斑内 VLA-4 的伴随激活相结合,对于在非 ST 段抬高型 MI 患者中比稳定型 CAD 患者更广泛地在炎症性动脉内皮上发生阻滞和穿胞作用是必需的。随后,在流体剪切力下,CD11c 从高亲和力状态向低亲和力状态的转换激活了磷酸化 Syk 和 ADAM17 介导的 CD16 的蛋白水解切割。这标志着 iMo 向与 NF-κB 核转位和 IL-1β 产生相关的炎症表型的转换。我们得出结论,CD11c 作为一种机械调节剂发挥作用,优先在大多数来自心脏患者而不是健康患者的 iMo 中激活炎症状态。